Ciprofloxacin-resistant Salmonella enterica Serotype Typhi, United States, 1999-2008

We report 9 ciprofloxacin-resistant Salmonella enterica serotype Typhi isolates submitted to the US National Antimicrobial Resistance Monitoring System during 1999-2008. The first 2 had indistinguishable pulsed-field gel electrophoresis patterns and identical gyrA and parC mutations. Eight of the 9...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Emerging infectious diseases 2011-06, Vol.17 (6), p.1095-1098
Hauptverfasser:	Medalla, Felicita, Sjölund-Karlsson, Maria, Shin, Sanghyuk, Harvey, Emily, Joyce, Kevin, Theobald, Lisa, Nygren, Benjamin N, Pecic, Gary, Gay, Kathryn, Austin, Jana, Stuart, Andrew, Blanton, Elizabeth, Mintz, Eric D, Whichard, Jean M, Barzilay, Esra J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Anti-Bacterial Agents - pharmacology antimicrobial drug resistance bacteria Child Child, Preschool Ciprofloxacin Ciprofloxacin - pharmacology Dispatch DNA Gyrase - genetics DNA Topoisomerase IV - genetics Drug resistance in microorganisms Drug Resistance, Bacterial - genetics Female fluoroquinolones Gene Expression Regulation, Bacterial - drug effects Genetic aspects Health aspects Humans Infant Male Microbial Sensitivity Tests Middle Aged Mutation - genetics Nucleic acids Salmonella Typhi Salmonella typhi - drug effects Salmonella typhi - genetics Salmonella typhi - isolation & purification Salmonella typhosa Separation typhoid fever Typhoid Fever - epidemiology Typhoid Fever - microbiology United States - epidemiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We report 9 ciprofloxacin-resistant Salmonella enterica serotype Typhi isolates submitted to the US National Antimicrobial Resistance Monitoring System during 1999-2008. The first 2 had indistinguishable pulsed-field gel electrophoresis patterns and identical gyrA and parC mutations. Eight of the 9 patients had traveled to India within 30 days before illness onset.
ISSN:	1080-6040 1080-6059
DOI:	10.3201/eid1706.100594